A detailed history of Great West Life Assurance CO transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 180,563 shares of IRWD stock, worth $910,037. This represents 0.0% of its overall portfolio holdings.

Number of Shares
180,563
Previous 152,492 18.41%
Holding current value
$910,037
Previous $1.33 Million 11.23%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$5.58 - $8.61 $156,636 - $241,691
28,071 Added 18.41%
180,563 $1.18 Million
Q1 2024

May 13, 2024

BUY
$8.32 - $15.45 $46,117 - $85,639
5,543 Added 3.77%
152,492 $1.33 Million
Q4 2023

Feb 13, 2024

SELL
$8.79 - $11.51 $897,441 - $1.18 Million
-102,098 Reduced 41.0%
146,949 $1.68 Million
Q3 2023

Nov 14, 2023

SELL
$8.25 - $11.35 $288,783 - $397,295
-35,004 Reduced 12.32%
249,047 $2.4 Million
Q2 2023

Aug 10, 2023

SELL
$10.1 - $11.6 $211,665 - $243,101
-20,957 Reduced 6.87%
284,051 $3.03 Million
Q1 2023

May 12, 2023

BUY
$10.37 - $12.56 $1.63 Million - $1.97 Million
156,751 Added 105.73%
305,008 $3.21 Million
Q4 2022

Feb 10, 2023

SELL
$9.9 - $12.43 $67,428 - $84,660
-6,811 Reduced 4.39%
148,257 $1.84 Million
Q3 2022

Nov 01, 2022

BUY
$10.14 - $12.38 $1.57 Million - $1.92 Million
155,068 New
155,068 $1.61 Million
Q2 2022

Aug 09, 2022

BUY
$11.05 - $12.72 $1.6 Million - $1.84 Million
144,945 Added 1811.81%
152,945 $1.77 Million
Q4 2021

Feb 14, 2022

SELL
$10.86 - $13.95 $345,054 - $443,233
-31,773 Reduced 79.89%
8,000 $93,000
Q3 2021

Nov 15, 2021

BUY
$11.92 - $13.92 $378,734 - $442,280
31,773 Added 397.16%
39,773 $523,000
Q2 2021

Aug 11, 2021

SELL
$10.16 - $13.11 $23,063 - $29,759
-2,270 Reduced 22.1%
8,000 $103,000
Q3 2020

Nov 17, 2020

BUY
$8.99 - $10.74 $81,826 - $97,755
9,102 Added 779.28%
10,270 $92,000
Q3 2020

Nov 13, 2020

SELL
$8.99 - $10.74 $81,826 - $97,755
-9,102 Reduced 88.63%
1,168 $10,000
Q2 2020

Aug 17, 2020

SELL
$9.14 - $11.97 $30,655 - $40,147
-3,354 Reduced 24.62%
10,270 $105,000
Q4 2019

Feb 11, 2020

BUY
$8.22 - $14.0 $111,989 - $190,736
13,624 New
13,624 $181,000
Q3 2019

Oct 25, 2019

SELL
$8.59 - $10.96 $170,013 - $216,920
-19,792 Closed
0 $0
Q1 2019

May 08, 2019

BUY
$8.27 - $12.73 $40,936 - $63,013
4,950 Added 33.35%
19,792 $267,000
Q3 2017

Nov 09, 2017

BUY
$12.07 - $14.87 $179,142 - $220,700
14,842
14,842 $235,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $772M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.